Vimpat (REMEDYREPACK INC.)


Welcome to the PulseAid listing for the Vimpat drug offered from REMEDYREPACK INC.. This Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: REMEDYREPACK INC.
NON-PROPRIETARY NAME: lacosamide
SUBSTANCE NAME: LACOSAMIDE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE]
ROUTE: ORAL
DOSAGE FORM: TABLET, FILM COATED
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2017-03-01
END MARKETING DATE: 0000-00-00


Vimpat HUMAN PRESCRIPTION DRUG Details:

Item DescriptionVimpat from REMEDYREPACK INC.
LABELER NAME: REMEDYREPACK INC.
DEA SCHEDULE: CV
ACTIVE STRENGTH: 100(mg/1)
START MARKETING DATE: 2017-03-01
END MARKETING DATE: 0000-00-00
PRODUCT ID: 70518-0257_5d80e6a5-d99b-c5b2-e053-2a91aa0a3343
PRODUCT NDC: 70518-0257
APPLICATION NUMBER: NDA022253

Other LACOSAMIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Amneal Pharmaceuticals of New York, LLCLacosamide
Breckenridge Pharmaceutical, Inc.LACOSAMIDE
Natco Pharma LimitedLacosamide
Physicians Total Care, Inc.Vimpat
REMEDYREPACK INC.Vimpat
UCB, Inc.Vimpat